Current Neuro-Oncology
Volume
27 Number 31
10 November 2025
Home > Publications > Current Neuro-Oncology > Volume 27, Year 2025 > Number 31, 10 November
Di Guglielmo FC, Bonaparte I, Davì
V, Guida P, Ciliberti MP, Gregucci F, Surgo A, Caliandro M,
Carbonara R, Giraldi D, Fanelli V, Surico G, Gentile MA, Calbi R,
Internò V, Laera L, Talienti T, Signorelli F, Lombardi G,
Fiorentino A.
Are
conventional and hypofractionated chemoradiotherapy comparable in
glioblastoma patients?
Clin
Transl Oncol.
2025 Nov 2. doi:
10.1007/s12094-025-04107-5. PMID:
41176740. Observational
study˰
ˍ
Ho VKY, Gijtenbeek JMM, Maas SLN, Taal W, van Linde ME, Broen MPG,
van Rij CM, van der Weide HL, Wagemakers M, Ter Laan M, de Vos
FYF, Bromberg JEC; Dutch Society for Neuro-Oncology (LWNO).
Adult
ependymoma: results from the Dutch Brain Tumour Registry on
primary treatment and survival.
J
Neurooncol. 2025 Nov 5;176(1):73. doi:
10.1007/s11060-025-05278-5. PMID:
41191161. Observational
study˰ ˍ
Ramamurthy K, Randazzo DM, Cort N, Herndon JE 2nd, Buckley E,
Affronti ML, Kim JY, Patel MP, Low JT, Johnson MO, Khasraw M,
Desjardins A, Ashley DM, Friedman HS, Peters KB.
Clinical
trial of feasibility for mindfulness intervention for patients
with newly diagnosed high grade glioma.
J
Neurooncol. 2025 Nov 5;176(1):71. doi:
10.1007/s11060-025-05325-1. PMID:
41191167. Interventional
study˰ ˍ
Yeboa DN, Whitfield BT, Lin R, Ejezie CL, Swanson TA, Beckham TH,
Wang C, De B, Perni S, Tom MC, Li J, McGovern SL, Harrison R, Majd
NK, Puduvalli VK, Aaroe AE, Loghin M, O'Brien BJ, Patel AD, Patel
CB, Wefel JS, Taslicay CA, Gule-Monroe M, Paulino AC, McAleer MF,
Grosshans DR, Ghia AJ, Jiang W, Chung C, Maor M, Yang CH,
Gubbiotti MA, Kamiya-Matsuoka C, Ballester LY, Weathers SP, Huse
JT.
Prospective phase II clinical
trial of molecular glioblastoma (historical grade 2 and 3 IDH
wildtype gliomas) preliminary novel exploratory analyses:
Treatment intensification, margin reduction and epigenetic
stratified outcomes with radiation therapy and chemotherapy.
J
Neurooncol. 2025 Nov 5;176(1):72. doi:
10.1007/s11060-025-05269-6. PMID:
41191157. Interventional study. ˍ
Chien DL, Hardy SJ, Serventi JN, Behr JM, Mohile NA, Hemminger LE.
Impact of radiation fractionation on
pseudoprogression in older patients with glioblastoma: a
retrospective cohort study.
CNS
Oncol. 2025 Nov 6;14(1):2584958. doi:
10.1080/20450907.2025.2584958. PMID:
41196722. Observational study. ˍ
Karatas D, Barut IT, Yıldırım Y, Adak AM, Arslan G,
Altunkan AA, Dagtekin A, Avci E.
Maternal
Neurosurgical Management of CNS Tumors During Pregnancy: A Case
Series With Long-Term Offspring Neurodevelopmental Follow-Up.
World
Neurosurg. 2025 Nov 6:124631. doi:
10.1016/j.wneu.2025.124631. PMID:
41205865. Observational study. ˍ
Arakawa Y, Saito R, Kanemura Y, Mishima K, Koriyama S, Narita Y,
Kumabe T, Motomura K, Sugiyama K, Yamasaki F, Mukasa A, Kanamori
M, Kuga D, Nagane M, Kakurai Y, Isobe K, Nakamura H.
Phase
II study of safusidenib erbumine in patients with chemotherapy-
and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO
grade 2 gliomas.
Neuro
Oncol. 2025 Nov 8:noaf258. doi:
10.1093/neuonc/noaf258. PMID:
41206766. Interventional
study.
ˍ
Gorter M, Röttgering JG, Belgers V, Blom MEC, Thomassen B, De
Witt Hamer PC, Niers JM, Kouwenhoven MCM, Bienfait HP, Gathier CS,
Compter A, Geurts M, Snijders TJ, Van De Ven PM, Douw L, Knoop H,
Klein M.
Bayesian Adaptive Randomized
Trial of Blended Cognitive Behavioral Therapy for Severe Fatigue
in Stable Diffuse Glioma.
Neuro
Oncol. 2025 Nov 9:noaf256. doi:
10.1093/neuonc/noaf256. PMID:
41208030. Interventional study. ˍ